BAY-204 (BRD3727) is a potent, ATP-competitive, and selective CSNK1alpha inhibitor (IC50 = 2 nM at 10 µM ATP, 12 nM at 1 mM ATP). BAY-204 can be used for the study of acute myeloid leukemia (AML)[1][2].
Molecular Weight:
533.54
Purity:
99.94
CAS Number:
[2468784-57-6]
Formula:
C29H26F3N5O2
Target:
Casein Kinase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted